FTSE 100 movers: Smith & Nephew jumps; Haleon in the red
London's FTSE 100 was down 0.3% at 8,117.38 in afternoon trade on Wednesday.
Smith & Nephew shot to the top of the index as it reported a 2.9% year-on-year rise in first-quarter revenue to $1.39bn, as its orthopaedics business continued to recover.
GSK also rallied as the pharmaceutical giant lifted annual profits guidance, pinning its hopes on demand for its respiratory virus and shingles treatments.
The company said it now expected a rise of 8% - 10% in annual adjusted earnings per share, up from the 6% - 9% previously forecast, while sales were tipped to be at the upper end of its 5% to 7% forecast range. Core operating profit growth was forecast to increase 9% - 11%, up from 7% - 10%.
Standard Chartered was in the black ahead of its first-quarter results on Thursday.
On the downside, Haleon slumped as the healthcare company's first-quarter revenue missed expectations.
FTSE 100 - Risers
Smith & Nephew (SN.) 1,006.00p 2.76%
GSK (GSK) 1,711.00p 2.27%
Severn Trent (SVT) 2,520.00p 2.15%
BT Group (BT.A) 104.75p 2.10%
Unite Group (UTG) 940.00p 1.29%
Airtel Africa (AAF) 112.30p 1.26%
Standard Chartered (STAN) 698.20p 1.22%
AstraZeneca (AZN) 12,204.00p 1.18%
Fresnillo (FRES) 564.50p 1.16%
United Utilities Group (UU.) 1,056.00p 1.10%
FTSE 100 - Fallers
Ashtead Group (AHT) 5,658.00p -3.15%
Ocado Group (OCDO) 344.00p -2.58%
JD Sports Fashion (JD.) 112.85p -2.38%
Haleon (HLN) 331.50p -2.36%
Schroders (SDR) 347.80p -1.42%
Frasers Group (FRAS) 805.50p -1.35%
M&G (MNG) 198.40p -1.34%
Persimmon (PSN) 1,287.00p -1.30%
Weir Group (WEIR) 2,024.00p -1.27%
BP (BP.) 514.20p -1.19%
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.